Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Faculty of Medicine Siriraj Hospital and Dhulikhel Hospital commemorate 15 years of collaborative relationship 2024-06-17 15:04
Ascentage Pharma Signs Option Agreement with Takeda to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI) 2024-06-14 21:30
Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer and Other Solid Tumors at the 2024 ESMO Virtual Plenary 2024-06-14 08:34
Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China 2024-06-13 22:33
Sirnaomics Demonstrates Strong Antitumor Activity of Its Novel Oligonucleotide-ChemoDrug Conjugate in Journal of Oncology Research and Therapy 2024-06-13 18:03
Innovent Receives Fast Track Designation from the U.S. FDA for IBI343 (TOPO1i anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer 2024-06-13 08:00
Ansell Recognized with the Frost & Sullivan 2024 Global Company of the Year Award for Revolutionizing Workplace Safety and Promoting Sustainability 2024-06-12 21:00
Latest Updates of Viva Biotech's Portfolio Companies 2024-06-12 19:51
Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific Sessions 2024-06-12 08:00
Last patient in: Laminar Pharmaceuticals S.A. completes recruitment for CLINGLIO, the phase 2b/3 Clinical Trial of idroxioleic acid (LAM561) in combination with RT and TMZ for adults with newly diagnosed glioblastoma 2024-06-12 02:15
Chengdu's influence being felt across the world 2024-06-11 16:44
Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE 2024-06-11 11:25
Element Six and Orbray partner to deliver the world's highest quality wafer-scale single crystal synthetic diamond 2024-06-11 08:00
Octapharma's continuing dedication to improving the lives of people with rare bleeding disorders to be showcased at ISTH 2024 2024-06-10 21:09
ILJIN SNT Co., Ltd. Announces Its Intention to Vote Against Aurinia Pharmaceuticals's Revised Equity Incentive Plan Proposal 2024-06-07 23:49
IONETIX Produces First Batch of Actinium-225 2024-06-07 20:27
Brii Bio Presents New Data from Its Ongoing Phase 2 Chronic Hepatitis B Trials at EASL™ Congress 2024 2024-06-07 19:00
Clinical Data of First-in-class HBV-specificTCR T Cell Therapy (SCG101) Presented at ESAL Congress Showing Improved Overall Survival in HBV-related Hepatocellular Carcinoma 2024-06-07 16:51
MLB Announces IND Approval by US FDA to Initiate Phase 1 Trial of TML-6, a New Era Multi-Target Drug for the Treatment of Alzheimer's Disease 2024-06-07 15:00
NDA for Luye Pharma's Rivastigmine Twice Weekly Transdermal Patch Filed in Japan for Treating Alzheimer's Dementia 2024-06-06 17:33
1 19 20 21 22 23 253